Send us a text

In this episode of the Life Science Success Podcast, Don Davis PhD, MBA interviews Igor Fisch, founder of NewBiologix. Igor shares his journey from academia to entrepreneurship, highlighting his success with Selexis, a company he sold in 2017 that specialized in monoclonal antibodies. He discusses the challenges of gene therapy, specifically the high costs, and NewBiologix's innovative approach to making gene therapy more affordable. Igor also provides insights into the industry's future, emphasizing the significance of stable production platforms for viral particles.

00:00 Introduction and Welcome

00:15 Igor's Journey into Life Sciences

00:37 The Success of Selexis

00:56 Transition to Gene Therapy

03:32 Challenges in Gene Therapy

03:50 The Importance of Stable Platforms

05:11 The Role of Biotech Startups

05:57 Balancing Science and Business

06:51 Networking at BIO Conference

08:14 Future Vision for New Biologics

09:21 Conclusion and Farewell